KEY FACTS

  • Diabetes mellitus is a multisystem disease resulting from defects in insulin secretion &/or resistance to insulin action, which culminates in systemic hyperglycemia, which can have negative effects, especially when chronically elevated.

    • The total prevalence of diabetes in the USA was 30.3 million people (9.4% of the population) in 2015, an increase of 50% since 2002. It is estimated that ~ 30% of all diabetics are undiagnosed.

  • The socioeconomic costs (direct and indirect) of diabetes were ~ $245 billion in 2012, a number that has almost doubled since 2002. An estimated 50% of the total costs for a diabetic hospital admission are due to diabetic foot complications.

    • Diabetic foot complications are the most common cause of atraumatic lower extremity amputations and are the leading cause of hospitalization among diabetics in the USA. Foot complications have a negative impact on the health-related quality of life of a diabetic patient, with fear of ulceration, recurrent infection, and potential lifelong disability.

    • There is currently no cure for diabetes, and treatment is based on preventing and managing the complications, requiring a multidisciplinary team approach and patient compliance.

A 64-year-old male patient with severe hindfoot Charcot and complete disassociation of the talus from the rest of the foot is shown. He was literally walking on the underside of his talus with skin breakdown in that area.

The patient is essentially weight bearing on the talus directly and had a medial wound in that area. The superior surface of the calcaneus
is seen superior to the level of the ankle mortise.

Severe Charcot midfoot with complete collapse of the arch is shown. The plantar prominence is readily apparent here; the risk for a plantar wound is significant. An equinus contracture often plays a large role in this midfoot "break."

The same patient shows essentially a dorsolateral subluxation midfoot injury in which the midfoot was the inflection point with the foot dorsiflexing and everting through the midfoot.

Diabetic Vascular Disease

Background

  • Peripheral arterial occlusive disease is 4x more prevalent in diabetics than in nondiabetics. It tends to occur at an earlier age in diabetics, and the risk of disease increases with the duration of diabetes.

  • The calcification of atherosclerotic plaques in arteries of diabetic patients is more diffuse and occurs within the tunica media of the arteries, producing a lead pipe appearance on plain radiographs (as opposed to plaques in nondiabetic patients, which are patchy and occur in the tunica intima).

  • The arterial occlusion of the proximal large vessels is similar to that in nondiabetics; however, the macrovascular disease is more diffuse in diabetics distal to the popliteal trifurcation. Distal vascular procedures have proven to be helpful in diabetic patients.

  • Microvascular complications of diabetes (neuropathy, retinopathy, and nephropathy) and macrovascular complications (peripheral vascular disease, coronary artery disease, hypertension, hyperlipidemia, and cerebrovascular disease) together contribute to diabetic foot problems.

Evaluation

  • A detailed history should be obtained, including a history of smoking, hypertension, and hyperlipidemia. Patients with advanced disease will complain of claudication.

  • Pain due to vascular claudication is usually relieved with rest. However, ischemic foot pain can also occur at rest.

  • On physical examination, absent popliteal or posterior tibial pulses, thin or shiny skin, absence of hair on the foot or leg, thickened nails, and dependent rubor are all signs of vascular insufficiency.

  • Any patient with signs of advanced vascular disease (such as a history of claudication, nonhealing ulcers, or nonpalpable pulses) should be evaluated by a vascular specialist.

Diagnostic Tests

  • Noninvasive vascular tests include the ankle-brachial index (ABI) using Doppler ultrasound pressures, transcutaneous oxygen (TcpO2) measurement (oximetry), the absolute toe systolic pressure (plethysmography), Doppler waveform analysis, and segmental Doppler limb pressures and pulse volume recordings.

  • Arterial pressure readings can be falsely elevated due to rigid arterial calcification in diabetics, which may artificially raise the ABI to > 1.00. Despite that, an ABI of < 0.80 is generally considered abnormal and < 0.45 in a diabetic patient is suggestive of limb-threatening ischemia.

  • Absolute toe pressures may be more predictive of distal wound healing with toe systolic pressure < 45 mm Hg indicating poor wound-healing potential and < 30 mm Hg indicating critical limb ischemia.

  • Transcutaneous oxygen measurement < 20-30 mm Hg represents poor wound-healing potential.

  • When assessing Doppler waveform recordings, a triphasic waveform is normal. Biphasic (loss of reverse flow in early diastole) and monophasic waveforms suggest advanced occlusive disease. If lower extremity ischemia is strongly suspected, arteriography, magnetic resonance angiography, or computed tomography angiography should be performed to assess the vascular flow.

Diabetic Neuropathy

Background

  • Peripheral neuropathy is the most common cause of diabetic foot complications. The presence of neuropathy (diabetic or otherwise) greatly increases the risk of complications from any surgery.

  • Diabetic neuropathy can involve the sensory, motor, and autonomic pathways.

  • Diabetic neuropathy has been estimated to occur in 58% of patients with longstanding disease, although 1 study noted that close to 80% of diabetic patients having surgery had some degree of neuropathy.

Sensory Neuropathy

  • The earliest finding in diabetic neuropathy is vibratory and proprioceptive loss. Signs and symptoms are variable but include paresthesias, burning sensations, hyperpathia, and dysesthesias and usually reveal a symmetric sensory loss in a "stocking-glove" distribution.

  • Due to the loss of protective (pain) sensation, foot ulceration generally occurs by repetitive trauma in areas of high mechanical pressure.

  • The 5.07 (10-g monofilament) Semmes-Weinstein monofilament (SWM) test of 7-10 plantar foot sites is the recommended screening test for a patient at risk for ulcer formation due to loss of protective sensation. However, up to 10% of patients who pass the SWM test may still develop skin breakdown.

  • A simplified screening test has been described. If a patient cannot sense the touch of a 4.5-g/4.65 SWM when it is pressed under the 1st metatarsal head with just enough pressure to bend the filament, the patient should be considered at risk for ulceration.

Autonomic Neuropathy

  • Denervation of the eccrine and apocrine glands and arteries leads to abnormal thermoregulation and interference with the normal hyperemic response to infection.

  • There is decreased sweating and loss of skin temperature regulation, causing dry, cracked skin and fissure formation, which predispose to infection by allowing a portal for bacterial entry.

  • Autonomic neuropathy can also cause orthostatic hypotension; cardiovascular, urinary, and gastrointestinal problems; and erectile dysfunction. It may produce chronic venous swelling, usually requiring management with compression stockings.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here